Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| translocation
|  
|  
|
translocation t(1;14) (p34,q11) or deletion in T cell acute lymphoblastic leukemia with worse response to treatment | tumoral
|  
|  
|  
| gain of function
|
Aberrant activation is involved in up to 60p100 of T cell acute lymphoblastic leukemia (T-ALL) cases, indicating that misregulation of TAL1's activity may lead to the development of T cell leukemia | tumoral
|  
|  
| --other
|  
|
with LYL1, aberrantly over-expressed in leukemia as a result of chromosomal translocations | tumoral
|  
|  
| --low
|  
|
by aberrant methylation of TAL1 in pediatric B-cell acute lymphoblastic leukemia (pMID: 25830127) | tumoral
|  
|  
|  
| gain of function
|
aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia | |